You are here: Home » PTI Stories » National » News
Business Standard

DUSA Pharmaceuticals Inc files additional claims in lawsuit against Biofrontera

Press Trust of India  |  New Delhi 

today said its arm DUSA has filed misappropriation and claims in an ongoing patent infringement lawsuit against Biofrontera.

has filed the claims "in an ongoing patent infringement lawsuit against Biofrontera Inc, Biofrontera Bioscience GmbH, Biofrontera Pharma GmbH, and in the District Court for the District of Massachusetts", said in a statement.

The lawsuit alleges patent infringement of DUSA's patents covering a product, Levulan Kerastic (aminolevulinic acid HCl), for 20 per cent used with its BLU-U blue light illuminator, it added.

The product is indicated for the treatment of minimally to of the face or scalp.

"In its amended complaint, DUSA additionally alleges that the Biofrontera defendants misappropriated confidential and information from DUSA and improperly obtained confidential DUSA information from former DUSA employees to sell and market defendants' own products," said.

The lawsuit seeks an assessment of both damages and injunctive relief against the Biofrontera defendants, it added.

The patents-in-suit concern an apparatus and method for 'photodynamic therapy' and equipment for the therapy, said.

The photodynamic therapy, pioneered by DUSA, combines a drug with a light source to treat conditions. The product was launched by DUSA in September 2000 in the US, it added.

Sun Pharma stock closed 0.28 per cent down at Rs 560.80 on BSE.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Wed, July 11 2018. 20:05 IST